{"id":"https://genegraph.clinicalgenome.org/r/42905cf9-2519-4ef7-a367-043c52422ac4v1.0","type":"EvidenceStrengthAssertion","dc:description":"MYSM1 was first reported in relation to autosomal recessive bone marrow syndrome in 2013 (Alsultan et al., PMID: 24288411). Bone marrow failure due to MYSM1 deficiency is characterized by anemia, leukopenia, thrombocytopenia, and B cell deficiency resulting in recurrent infections and in some cases, non hematologic features such as dysmorphic features, skeletal abnormalities, and developmental delay. At least seven variants (e.g. missense, nonsense, frameshift, and canonical splice) that have been reported in seven probands in seven publications (PMIDs: 24288411, 28115216, 26220525, 33858043, 30735661, 32640305, 35295078) are included in this curation. MYSM1 variants segregated with disease in two families and heterozygous carriers were asymptomatic (PMIDs: 28115216, 24288411). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by mouse models, in vivo genetic reversion in an affected patient, biochemical function, functional alteration, and protein interactions studies. (PMIDs: 26125289, 26474655, 22184403, 26220525, 28115216). In summary, there is definitive evidence supporting the relationship between MYSM1 and autosomal recessive bone marrow failure. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen SCID-CID GCEP on June 7, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/42905cf9-2519-4ef7-a367-043c52422ac4","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2024-06-07T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2024-06-28T17:50:40.736Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ecd696a-c552-4059-bcdb-a5ffc73417e4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7fa11bc-c105-420e-a622-5ed46a4768e2","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7fa11bc-c105-420e-a622-5ed46a4768e2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30735661","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fd28f67-d3ed-4c29-9b0b-0bfc6ad18986","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001085487.3(MYSM1):c.1432C>T (p.Arg478del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA877815"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/4ecd696a-c552-4059-bcdb-a5ffc73417e4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30735661","rdfs:label":"DBA Patient","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fd28f67-d3ed-4c29-9b0b-0bfc6ad18986"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Clinical diagnosis or strong suspicion of DBA. \"The diagnosis of DBA was based on normochromic often macrocytic anemia, reticulocytopenia, bone marrow eryth- roblastopenia, and in some individuals, physical abnormalities and elevated erythrocyte adenosine deaminase activity.\"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d7fa11bc-c105-420e-a622-5ed46a4768e2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/207bd0ed-8ab7-4d47-944e-1b9b33f2781e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9395bd4d-1fc0-45ab-9f36-afc0364f1203","type":"EvidenceLine","dc:description":"Took off a half point for consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9395bd4d-1fc0-45ab-9f36-afc0364f1203_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24288411","allele":{"id":"https://genegraph.clinicalgenome.org/r/befaf4bb-6604-4d9a-b6e9-c2802d6f64c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001085487.3(MYSM1):c.1168G>T (p.Glu390del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340524847"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/207bd0ed-8ab7-4d47-944e-1b9b33f2781e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24288411","rdfs:label":"Index","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/befaf4bb-6604-4d9a-b6e9-c2802d6f64c5"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001903","obo:HP_0005528"],"previousTesting":true,"previousTestingDescription":"Autozygosity mapping","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9395bd4d-1fc0-45ab-9f36-afc0364f1203_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5e2d9c89-42ea-49d5-b11c-46bee48ac469_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9450a086-bdb5-4460-bdd3-95cc8ceca1ae","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9450a086-bdb5-4460-bdd3-95cc8ceca1ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32640305","allele":{"id":"https://genegraph.clinicalgenome.org/r/1172a3ef-a5a9-4392-a6c1-0d1cf64519b5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001085487.3(MYSM1):c.1467C>G (p.Tyr489del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340521330"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ead20c09-d4da-4c7f-92c2-57b65adfa0f9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ead20c09-d4da-4c7f-92c2-57b65adfa0f9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR showed that this variant cause exon 6 skipping which results in a premature stop codon (c.321_399 del, p.V108Lfs*13) (Fig. 2D).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ead20c09-d4da-4c7f-92c2-57b65adfa0f9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32640305","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b3e57b3-58a9-4a28-9fd8-4e99bc35c152","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001085487.3(MYSM1):c.399G>A (p.Leu133=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA417986757"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5e2d9c89-42ea-49d5-b11c-46bee48ac469","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32640305","rdfs:label":"Chinese Female","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/2b3e57b3-58a9-4a28-9fd8-4e99bc35c152"},{"id":"https://genegraph.clinicalgenome.org/r/1172a3ef-a5a9-4392-a6c1-0d1cf64519b5"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"\"Further analysis of her lymphocyte subpopulations showed a marked reduction in peripheral CD19+ and CD16+ CD56+ cells, suggesting B-cell and NK-cell deficiency.\"","phenotypes":["obo:HP_0001882","obo:HP_0005528","obo:HP_0001873","obo:HP_0002205","obo:HP_0001903"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/9450a086-bdb5-4460-bdd3-95cc8ceca1ae_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ead20c09-d4da-4c7f-92c2-57b65adfa0f9_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c31b6cef-83ab-40af-b80f-b33ff66427d3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24288411","rdfs:label":"Saudi Arabian ","estimatedLodScore":1.1,"family":{"id":"https://genegraph.clinicalgenome.org/r/c31b6cef-83ab-40af-b80f-b33ff66427d3","type":"Family","rdfs:label":"Saudi Arabian ","member":{"id":"https://genegraph.clinicalgenome.org/r/207bd0ed-8ab7-4d47-944e-1b9b33f2781e"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0005528","obo:HP_0001903"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/207bd0ed-8ab7-4d47-944e-1b9b33f2781e"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e5a32a7c-d520-4234-985c-8a0efc99c88e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28115216","rdfs:label":"Arab","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/e5a32a7c-d520-4234-985c-8a0efc99c88e","type":"Family","rdfs:label":"Arab","member":{"id":"https://genegraph.clinicalgenome.org/r/d9cf48b8-f2ab-4817-8d7b-0313f72a983f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28115216","rdfs:label":"IV.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/befaf4bb-6604-4d9a-b6e9-c2802d6f64c5"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002205","obo:HP_0001903","obo:HP_0004322","obo:HP_0005528"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d3ae7673-707c-459a-8ddb-a3c24d11e191_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28115216","allele":{"id":"https://genegraph.clinicalgenome.org/r/befaf4bb-6604-4d9a-b6e9-c2802d6f64c5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0004322","obo:HP_0005528","obo:HP_0002205","obo:HP_0001903"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d9cf48b8-f2ab-4817-8d7b-0313f72a983f"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d9cf48b8-f2ab-4817-8d7b-0313f72a983f_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3ae7673-707c-459a-8ddb-a3c24d11e191","type":"EvidenceLine","dc:description":"Not scoring since I already scored a family with this variant. ","calculatedScore":4,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3ae7673-707c-459a-8ddb-a3c24d11e191_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"\"To study the consequences of this mutation leading to a premature stop codon in exon 9 (SWIRM domain), we generated anti-MYSM1 mAbs. As shown in Fig 3, B, MYSM1 could not be detected at the expected size in EBV-LCLs generated from the patients, whereas a 110-kDa band representing wild-type MYSM1 was seen in cells from parents.\"","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d3ae7673-707c-459a-8ddb-a3c24d11e191_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/d9cf48b8-f2ab-4817-8d7b-0313f72a983f"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/4f0d50e3-9210-47a4-8012-e9ffa8c1188c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54b6abf3-2d04-48c6-b193-e87b23343613","type":"EvidenceLine","dc:description":"Downgraded for consanguinity","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54b6abf3-2d04-48c6-b193-e87b23343613_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35295078","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d30b7ee-2ea7-4ddf-a84d-e7a3d42961bc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001085487.3(MYSM1):c.2329-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340517744"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4f0d50e3-9210-47a4-8012-e9ffa8c1188c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35295078","rdfs:label":"5112","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5d30b7ee-2ea7-4ddf-a84d-e7a3d42961bc"},"detectionMethod":"\"For variant detection, we used Sanger sequencing of commonly mutated genes and a custom-made targeted next-generation sequencing panel covering 226 genes known to be mutated in inherited cytopenias; the minority subsequently underwent whole exome sequencing.\"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"dysmorphic features","phenotypes":["obo:HP_0001873","obo:HP_0005528"],"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/54b6abf3-2d04-48c6-b193-e87b23343613_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c80ba036-a85c-4af0-abbe-608d0a73cde7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fa417cd-ff68-4349-afe5-757ba13ffa9e","type":"EvidenceLine","dc:description":"Took off a half point for consanguinity.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fa417cd-ff68-4349-afe5-757ba13ffa9e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"\"Moreover, immunofluorescence study indicated that the endogenous mutant MYSM1, although correctly located in the nucleus, was weakly detected in the patient’s fibro- blasts compared with that seen in control fibroblasts (Fig 2, E). Western blot analysis confirmed the reduced amount of endoge- nous MYSM1 in the patient’s fibroblast whole-cell lysates (Fig 2, F).\"","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6fa417cd-ff68-4349-afe5-757ba13ffa9e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26220525","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f2860e5-12d0-433c-8815-fbe39f638623","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001085487.3(MYSM1):c.1967A>G (p.His656Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340519299"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c80ba036-a85c-4af0-abbe-608d0a73cde7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26220525","rdfs:label":"Turkish Male","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f2860e5-12d0-433c-8815-fbe39f638623"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"complete lack of B lymphocytes, T-cell lymphopenia, defective hematopoiesis","phenotypes":["obo:HP_0000252","obo:HP_0002205","obo:HP_0001903"],"previousTesting":true,"previousTestingDescription":"Whole-genome homozygosity mapping","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6fa417cd-ff68-4349-afe5-757ba13ffa9e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7346849e-bb69-4b64-8e4d-5d4e173ce0d7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb6aa495-bc09-45ca-b96a-4149e37560ee","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb6aa495-bc09-45ca-b96a-4149e37560ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33858043","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fd28f67-d3ed-4c29-9b0b-0bfc6ad18986"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cf9e483e-d357-4966-9e40-777aa0cc6623","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf9e483e-d357-4966-9e40-777aa0cc6623_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33858043","allele":{"id":"https://genegraph.clinicalgenome.org/r/581f6596-8387-4837-8e32-2d13172e6895","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001085487.3(MYSM1):c.1607_1611del (p.Glu536GlyfsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2586966694"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7346849e-bb69-4b64-8e4d-5d4e173ce0d7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33858043","rdfs:label":"Chinese Female","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":1,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/581f6596-8387-4837-8e32-2d13172e6895"},{"id":"https://genegraph.clinicalgenome.org/r/1fd28f67-d3ed-4c29-9b0b-0bfc6ad18986"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001903","obo:HP_0001882","obo:HP_0001873"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bb6aa495-bc09-45ca-b96a-4149e37560ee_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cf9e483e-d357-4966-9e40-777aa0cc6623_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c850ae5-8204-44dd-9118-2facfe7eabf8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a63906a-cfed-4063-92da-e5436dd06202","type":"Finding","dc:description":"Symptoms of anemia, lymphopenia, and thrombocytosis were found in affected humans and mice. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22184403","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4ad147e0-361b-4994-9809-2d4168df553c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f34136e6-a622-44e9-bfb2-da0902e9cd2d","type":"Finding","dc:description":"The patient had spontaneous improvement of the patient’s immunohematologic features, including a correction in the number of circulating T and NK lymphocytes, reticulocytes, and neutrophils (Fig 3, A) strikingly, circulating B lymphocytes (CD19 ), which were completely absent in the patient at age 4 months (Table I), were detected at a normal level at 33 and 39 months of age (Fig 3, A). Then we amplified and directly sequenced the MYSM1 gene in the patient’s B cells to seek after a possible genetic reversion. Unlike the patient’s fibroblasts that carried the homozygous MYSM1 mutation (Figs 2, B, and 3, B), the patient’s B lymphocytes were heterozygous for the mutation (Fig 3, B), indicating a spontaneous in vivo reversion to normal of inherited mutation on one allele. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26220525","rdfs:label":"In vivo Genetic Reversion","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee8d527d-5f3e-45bc-8efe-4ca88df565ae","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7f9d783-bff3-4d28-b8d3-dd12317d40f5","type":"FunctionalAlteration","dc:description":"MYSM1 deficient fetal livers have a significant reduction in hematopoietic cells, specifically B lymphoid lineage cells and fetal liver cells were severely impaired in their contribution to hematopoiesis in the recipient mice (mice transplanted with fetal liver\ncells into irradiated recipients, either alone, or in a direct 1:1 competition with allotype marked wild-type fetal liver cells.)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26125289","rdfs:label":"Defect in Hematopoiesis"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ee22e44c-4239-47f4-b971-c8b5012b8a1c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62eaafdd-f548-4f65-8230-21df489c3d95","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0001a99e-5a51-48bd-b448-baa0370d1504","type":"Finding","dc:description":"Affected patients exhibit bone marrow failure which could be induced by increased susceptibility to genotoxic stress.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28115216","rdfs:label":"Increased genotoxic stress in MYSM1-deficient cells","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b72d2190-6e46-48ab-9cd3-a504af6cec93","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e2dd13d-92ae-4dc1-8937-b88ec5af0908","type":"Finding","dc:description":"MYSM1 interacted with and inactivated TRAF3 and TRAF6 complexes to terminate PRR pathways for pro-inflammatory and type I interferon responses","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26474655","rdfs:label":"TRAF3 and TRAF6 complexes","demonstrates":{"id":"obo:MI_0935"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":8531,"specifiedBy":"GeneValidityCriteria10","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/jMyNYYJDtLk","type":"GeneValidityProposition","disease":"obo:MONDO_0020856","gene":"hgnc:29401","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ee22e44c-4239-47f4-b971-c8b5012b8a1c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}